Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
J Affect Disord ; 234: 139-147, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29529546

RESUMEN

BACKGROUND: Glycans are short chains of saccharides linked to glycoproteins that are known to be involved in a wide range of inflammatory processes. As depression has been consistently associated with chronic low-grade inflammation, we asked whether patients with Major Depressive Disorder show alterations in the N-glycosylation pattern of serum proteins that might be linked to associated changes in inflammatory processes. METHODS: In a study cohort of 21 female patients with an acute depressive episode and 21 non-depressed female control subjects aged between 50 and 69 years, we analyzed the serum N-glycan profile by DNA Sequencer Adapted-Fluorophore Assisted Carbohydrate Electrophoresis (DSA-FACE) and assessed the serum levels of interleukin (IL)- 6, tumor necrosis factor (TNF)-α and C-reactive protein (CRP) by chemiluminescence immunoassays and nephelometry. RESULTS: Compared to controls, MDD patients showed significant differences in the serum levels of several N-glycan structures. Alterations in the serum N-glycan profile were associated with depressive symptom severity and exploratory analyses revealed that they were most pronounced in MDD patients with a history of childhood sexual abuse. Furthermore, MDD patients showed higher levels of IL-6 and a trend for higher CRP levels, which were also associated with similar alterations in the serum N-glycan profile as those characteristic for MDD patients. LIMITATIONS: The relatively small sample size and the presence of potential confounders (e.g., BMI, smoking, medication). CONCLUSION: The results offer the first evidence that specific differences in the N-glycosylation pattern of serum proteins constitute a so far unrecognized level of biological alterations that might be involved in the immune changes associated with MDD.


Asunto(s)
Trastorno Depresivo Mayor/sangre , Inflamación/sangre , Polisacáridos/sangre , Anciano , Biomarcadores/sangre , Proteína C-Reactiva/análisis , Estudios de Casos y Controles , Trastorno Depresivo Mayor/complicaciones , Femenino , Humanos , Inflamación/complicaciones , Interleucina-6/sangre , Persona de Mediana Edad , Factor de Necrosis Tumoral alfa/sangre
2.
EMBO Mol Med ; 8(10): 1162-1183, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27596437

RESUMEN

Here, we identified release of extracellular vesicles (EVs) by the choroid plexus epithelium (CPE) as a new mechanism of blood-brain communication. Systemic inflammation induced an increase in EVs and associated pro-inflammatory miRNAs, including miR-146a and miR-155, in the CSF Interestingly, this was associated with an increase in amount of multivesicular bodies (MVBs) and exosomes per MVB in the CPE cells. Additionally, we could mimic this using LPS-stimulated primary CPE cells and choroid plexus explants. These choroid plexus-derived EVs can enter the brain parenchyma and are taken up by astrocytes and microglia, inducing miRNA target repression and inflammatory gene up-regulation. Interestingly, this could be blocked in vivo by intracerebroventricular (icv) injection of an inhibitor of exosome production. Our data show that CPE cells sense and transmit information about the peripheral inflammatory status to the central nervous system (CNS) via the release of EVs into the CSF, which transfer this pro-inflammatory message to recipient brain cells. Additionally, we revealed that blockage of EV secretion decreases brain inflammation, which opens up new avenues to treat systemic inflammatory diseases such as sepsis.


Asunto(s)
Barrera Hematoencefálica/patología , Encéfalo/patología , Plexo Coroideo/metabolismo , Vesículas Extracelulares/metabolismo , Inflamación/patología , Animales , Células Cultivadas , Líquido Cefalorraquídeo/química , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Factores Inmunológicos/metabolismo , Lipopolisacáridos/metabolismo , Ratones Endogámicos C57BL , MicroARNs/análisis , Técnicas de Cultivo de Órganos
3.
Exp Mol Pathol ; 100(1): 26-30, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26655437

RESUMEN

Posttranslational modifications (PTM) which accompany pathological conditions affect protein structure, characteristics and modulate its activity. Glycosylation is one of the most frequent PTM influencing protein folding, localisation and function. Hypertension is a common gestational complication, which can lead to foetal growth restriction (IUGR) and even to foetal or maternal death. In this work we focused on the impact of preeclampsia complicated with IUGR on placental membrane N-glycome. Results have shown that preeclampsia reduced fucosylation of placental glycans, increased the appearance of paucimannosidic and mannosidic structures with lower number of mannose residues and decreased the amount of glycans with more mannose residues. Since preeclampsia is tightly connected to IUGR, glycosylation changes were investigated also on the functional membrane receptors responsible for growth: insulin receptor and the type 1 insulin-like growth factor receptor (IR and IGF1R). It was found that IR present in the IUGR placenta contained significantly less α2,6-Sia. Therefore, glycans on placental membranes alter due to preeclampsia, but changes seen at the level of the entire N-glycome may be different from the changes detected at the level of a specific glycoprotein. The difference recorded due to pathology in one membrane molecule (IR) was not found in another homologous molecule (IGF1R). Thus, besides studying the glycosylation pattern of the entire placental membrane due to preeclampsia, it is inevitable to study directly glycoprotein of interest, as no general assumptions or extrapolations can be made.


Asunto(s)
Membrana Celular/metabolismo , Glicoproteínas/metabolismo , Placenta/metabolismo , Preeclampsia/metabolismo , Endotelio Vascular/metabolismo , Endotelio Vascular/patología , Femenino , Glicosilación , Humanos , Hipertensión/metabolismo , Embarazo
4.
J Am Heart Assoc ; 4(11)2015 Nov 23.
Artículo en Inglés | MEDLINE | ID: mdl-26597154

RESUMEN

BACKGROUND: Silent brain infarcts (SBIs) are highly prevalent in the aged population and relate to the occurrence of further stroke and dementia. Serum N-glycome levels have been previously associated with aging and they might be related as well to the presence of SBIs and age-related white matter hyperintensities. METHODS AND RESULTS: We determined the serum N-glycome profile in a cohort study comprising 972 subjects and evaluated the relationship between N-glycome levels and the presence and number of SBIs and with age-related white matter hyperintensities grades, assessed by brain magnetic resonance imaging. Decreasing concentrations of bigalacto core-α-1,6-fucosylated biantennary glycan and increasing concentrations of branching α-1,3-fucosylated triantennary glycan remained as independent predictors of SBIs (odds ratio 0.4, 95% CI 0.3-0.7 and odds ratio 1.8, 95% CI 1-3.2, respectively), after controlling for the presence of age and classic vascular risk factors. A similar pattern was found to be related to an increasing number of SBIs and white matter hyperintensities grade. CONCLUSIONS: N-glycome levels might be potentially useful as biomarkers for the presence of silent cerebrovascular disease.


Asunto(s)
Infarto Encefálico/sangre , Glicómica/métodos , Hipertensión/sangre , Leucoencefalopatías/sangre , Polisacáridos/sangre , Anciano , Enfermedades Asintomáticas , Biomarcadores/sangre , Infarto Encefálico/etiología , Infarto Encefálico/patología , Distribución de Chi-Cuadrado , Estudios de Cohortes , Femenino , Humanos , Hipertensión/complicaciones , Hipertensión/diagnóstico , Leucoencefalopatías/etiología , Leucoencefalopatías/patología , Modelos Lineales , Modelos Logísticos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Valor Predictivo de las Pruebas , Factores de Riesgo
5.
J Proteome Res ; 14(10): 4232-45, 2015 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-26334954

RESUMEN

In recent years, plasma N-glycans have emerged as biomarkers for health and disease. Here, we studied N-glycomic changes in Down Syndrome (DS). Because of the progeroid phenotype of DS, we focused on the dissection of syndrome- and aging-associated glycomic changes, as well as the interaction thereof. We analyzed the plasma N-glycome of 76 DS persons, 37 siblings (DSS), and 42 mothers (DSM) of DS persons by DNA-sequencer-aided, fluorophore-assisted-carbohydrate-electrophoresis, as well as by matrix-assisted laser desorption ionization-time-of-flight-mass spectrometry (MALDI-TOF-MS). The results showed an overall decrease of galactosylation and α2,3 sialylation, a concomitant increase of the level of fucosylated N-glycans as well as of monogalactosylated diantennary N-glycans in DS, while the GlycoAgeTest and the ratio of the two core-fucosylated, monogalactosylated diantennary isomers (galactose positioned on α1,6 arm versus α1,3 arm) were the strongest DS discriminators. Hypogalactosylation is a characteristic of both DS and aging of control individuals. A decrease in α2,3-sialylated species is also common to DS and aging of controls. However, regarding to α2,6-sialylated tri- and tetragalactosylated N-glycan species, we found those to be lowered in DS but showed an increase with age in the same persons, while these glycans were not affected by aging in control individuals. In conclusion, we identified specific glycomic changes associated with DS, aging in DS, as well as aging in controls, identifying glycomic features in line with accelerated aging in DS. Notably, our data demonstrate an aging phenotype in DS which only in part overlaps with aging in controls but reveals DS-specificity.


Asunto(s)
Envejecimiento/sangre , Síndrome de Down/sangre , Glicómica/métodos , Polisacáridos/sangre , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Metabolismo de los Hidratos de Carbono , Secuencia de Carbohidratos , Estudios de Casos y Controles , Niño , Síndrome de Down/patología , Femenino , Fucosa/sangre , Fucosa/química , Galactosa/sangre , Galactosa/química , Glicosilación , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Madres , Polisacáridos/química , Ácidos Siálicos/sangre , Ácidos Siálicos/química , Hermanos , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
6.
Mech Ageing Dev ; 151: 71-84, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25846863

RESUMEN

Changes in the abundance and post-translational modification of proteins and accumulation of some covalently modified proteins have been proposed to represent hallmarks of biological ageing. Within the frame of the Mark-Age project, the workpackage dedicated to "markers based on proteins and their modifications" has been firstly focused on enzymatic and non-enzymatic post-translational modifications of serum proteins by carbohydrates. The second focus of the workpackage has been directed towards protein maintenance systems that are involved either in protein quality control (ApoJ/Clusterin) or in the removal of oxidatively damaged proteins through degradation and repair (proteasome and methionine sulfoxide reductase systems). This review describes the most relevant features of these protein modifications and maintenance systems, their fate during ageing and/or their implication in ageing and longevity.


Asunto(s)
Longevidad/fisiología , Procesamiento Proteico-Postraduccional/fisiología , Proteolisis , Animales , Biomarcadores/metabolismo , Humanos , Oxidación-Reducción
7.
PLoS One ; 10(3): e0119983, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25793407

RESUMEN

BACKGROUND: Glycosylation, i.e the enzymatic addition of oligosaccharides (or glycans) to proteins and lipids, known as glycosylation, is one of the most common co-/posttranslational modifications of proteins. Many important biological roles of glycoproteins are modulated by N-linked oligosaccharides. As glucose levels can affect the pathways leading to glycosylation of proteins, we investigated whether metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM), pathological conditions characterized by altered glucose levels, are associated with specific modifications in serum N-glycome. METHODS: We enrolled in the study 562 patients with Type 2 Diabetes Mellitus (T2DM) (mean age 65.6±8.2 years) and 599 healthy control subjects (CTRs) (mean age, 58.5±12.4 years). N-glycome was evaluated in serum glycoproteins. RESULTS: We found significant changes in N-glycan composition in the sera of T2DM patients. In particular, α(1,6)-linked arm monogalactosylated, core-fucosylated diantennary N-glycans (NG1(6)A2F) were significantly reduced in T2DM compared with CTR subjects. Importantly, they were equally reduced in diabetic patients with and without complications (P<0.001) compared with CTRs. Macro vascular-complications were found to be related with decreased levels of NG1(6)A2F. In addition, NG1(6)A2F and NG1(3)A2F, identifying, respectively, monogalactosylated N-glycans with α(1,6)- and α(1,3)-antennary galactosylation, resulted strongly correlated with most MS parameters. The plasmatic levels of these two glycans were lower in T2DM as compared to healthy controls, and even lower in patients with complications and MS, that is the extreme "unhealthy" phenotype (T2DM+ with MS). CONCLUSIONS: Imbalance of glycosyltransferases, glycosidases and sugar nucleotide donor levels is able to cause the structural changes evidenced by our findings. Serum N-glycan profiles are thus sensitive to the presence of diabetes and MS. Serum N-glycan levels could therefore provide a non-invasive alternative marker for T2DM and MS.


Asunto(s)
Proteínas Sanguíneas/metabolismo , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/metabolismo , Glicómica , Síndrome Metabólico/complicaciones , Síndrome Metabólico/metabolismo , Polisacáridos/metabolismo , Anciano , Estudios de Casos y Controles , Femenino , Glicómica/métodos , Glicoproteínas/sangre , Glicoproteínas/metabolismo , Humanos , Masculino , Persona de Mediana Edad
8.
Mech Ageing Dev ; 138: 1-9, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24525093

RESUMEN

Alterations in the glycosylation of few membrane proteins from human placenta during gestation have been documented, but data on N-glycome of placental membrane proteins are still missing. The primary goal of this study was to obtain N-glycan profiles of human placental membrane proteins using a reliable, simple and high-throughput method. The second goal was to examine whether the N-glycan profile alters during gestation. Placental membrane proteins were isolated from women of different ages after first and third trimesters of pregnancy. The N-glycan fingerprint of membrane proteins was obtained using DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis (DSA-FACE). Lectin blotting was used to confirm DSA-FACE results. Observed gestation-related alterations were: greater abundance of core-fucosylated and multiantennary N-glycans, but lower amounts of bisected biantennary N-glycans together with a decrease in α2,3-sialylation. Age-related alterations were: more core Fuc and more α2,3-Sia in first trimester placentas from older women than in those from younger women; also less core Fuc and less α2,6-Sia in third trimester placentas from older women compared to those from younger women. This study represents the first N-glycan profiling of placental cell membrane proteins. These data represent a basis for future research on the N-glycome of placental proteins in different (patho)physiological conditions.


Asunto(s)
Placenta/metabolismo , Polisacáridos , Adulto , Electroforesis en Gel de Poliacrilamida/métodos , Femenino , Edad Gestacional , Humanos , Edad Materna , Glicoproteínas de Membrana/análisis , Glicoproteínas de Membrana/metabolismo , Placentación/fisiología , Polisacáridos/análisis , Polisacáridos/metabolismo , Embarazo , Proteínas Gestacionales/análisis , Proteínas Gestacionales/metabolismo , Trimestres del Embarazo/fisiología , Reproducibilidad de los Resultados , alfa-L-Fucosidasa/metabolismo , alfa-L-Fucosidasa/farmacología
9.
PLoS One ; 8(12): e79883, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24339869

RESUMEN

Glycosylation is an essential post-translational modification, which determines the function of proteins and important processes such as inflammation. ß-1,4-galactosyltransferase I (ßGalT1) is a key enzyme involved in the addition of galactose moieties to glycoproteins. Intestinal mucins are glycoproteins that protect the gut barrier against invading pathogens and determine the composition of the intestinal microbiota. Proper glycosylation of mucus is important in this regard. By using ubiquitously expressing ßGalT1 transgenic mice, we found that this enzyme led to strong galactosylation of mucus proteins, isolated from the gut of mice. This galactosylation was associated with a drastic change in composition of gut microbiota, as TG mice had a significantly higher Firmicutes to Bacteroidetes ratio. TG mice were strongly protected against TNF-induced systemic inflammation and lethality. Moreover, ßGalT1 transgenic mice were protected in a model of DSS-induced colitis, at the level of clinical score, loss of body weight, colon length and gut permeability. These studies put ßGalT1 forward as an essential protective player in exacerbated intestinal inflammation. Optimal galactosylation of N-glycans of mucus proteins, determining the bacterial composition of the gut, is a likely mechanism of this function.


Asunto(s)
Colitis/inducido químicamente , Colitis/genética , Sulfato de Dextran/efectos adversos , Galactosiltransferasas/genética , Factor de Necrosis Tumoral alfa/efectos adversos , Animales , Susceptibilidad a Enfermedades , Femenino , Expresión Génica , Humanos , Inflamación/inducido químicamente , Inflamación/genética , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/microbiología , Ratones , Ratones Transgénicos , Microbiota/efectos de los fármacos , Fenotipo
10.
Ageing Res Rev ; 12(2): 685-98, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22353383

RESUMEN

Glycosylation is a frequent co/post-translational modification of proteins which modulates a variety of biological functions. The analysis of N-glycome, i.e. the sugar chains N-linked to asparagine, identified new candidate biomarkers of aging such as N-glycans devoid of galactose residues on their branches, in a variety of human and experimental model systems, such as healthy old people, centenarians and their offspring and caloric restricted mice. These agalactosylated biantennary structures mainly decorate Asn297 of Fc portion of IgG (IgG-G0), and are present also in patients affected by progeroid syndromes and a variety of autoimmune/inflammatory diseases. IgG-G0 exert a pro-inflammatory effect through different mechanisms, including the lectin pathway of complement, binding to Fcγ receptors and formation of autoantibody aggregates. The age-related accumulation of IgG-G0 can contribute to inflammaging, the low-grade pro-inflammatory status that characterizes elderly, by creating a vicious loop in which inflammation is responsible for the production of aberrantly glycosylated IgG which, in turn, would activate the immune system, exacerbating inflammation. Moreover, recent data suggest that the N-glycomic shift observed in aging could be related not only to inflammation but also to alteration of important metabolic pathways. Thus, altered N-glycans are both powerful markers of aging and possible contributors to its pathogenesis.


Asunto(s)
Envejecimiento/metabolismo , Retroalimentación Fisiológica , Glicosilación , Inmunoglobulina G/metabolismo , Polisacáridos/metabolismo , Anciano , Animales , Asparagina/metabolismo , Enfermedades Autoinmunes/metabolismo , Biomarcadores/metabolismo , Lectina de Unión a Manosa de la Vía del Complemento , Glicómica , Humanos , Inflamación/metabolismo , Ratones , Modelos Teóricos , Progeria/metabolismo , Procesamiento Proteico-Postraduccional
11.
Ageing Res Rev ; 12(1): 8-21, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22543101

RESUMEN

The mouse has become the favorite mammalian model. Among the many reasons for this privileged position of mice is their genetic proximity to humans, the possibilities of genetically manipulating their genomes and the availability of many tools, mutants and inbred strains. Also in the field of aging, mice have become very robust and reliable research tools. Since laboratory mice have a life expectancy of only a few years, genetic approaches and other strategies for intervening in aging can be tested by examining their effects on life span and aging parameters during the relatively short period of, for example, a PhD project. Moreover, experiments on mice with an extended life span as well as on mice demonstrating signs of (segmental) premature aging, together with genetic mapping strategies, have provided novel insights into the fundamental processes that drive aging. Finally, the results of studies on caloric restriction and pharmacological anti-aging treatments in mice have a high degree of relevance to humans. In this paper, we review a number of recent genetic mapping studies that have yielded novel insights into the aging process. We discuss the value of the mouse as a model for testing interventions in aging, such as caloric restriction, and we critically discuss mouse strains with an extended or a shortened life span as models of aging.


Asunto(s)
Envejecimiento/fisiología , Ratones/fisiología , Animales , Restricción Calórica , Cruzamientos Genéticos , Humanos , Hipofisectomía , Esperanza de Vida , Longevidad/efectos de los fármacos , Metionina/fisiología , Ratones Endogámicos , Ratones Noqueados , Ratones Mutantes , Modelos Biológicos , Modelos Genéticos , Valores de Referencia , Investigación
12.
Aging Cell ; 10(6): 1056-66, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21951615

RESUMEN

We recently reported that N-glycosylation changes during human aging. To further investigate the molecular basis determining these alterations, the aging process in mice was studied. N-glycan profiling of mouse serum glycoproteins in different age groups of healthy C57BL/6 mice showed substantial age-related changes in three major N-glycan structures: under-galactosylated biantennary (NGA2F), biantennary (NA2), and core α-1,6-fucosylated -ß-galactosylated biantennary structures (NA2F). Mice defective in klotho gene expression (kl/kl), which have a shortened lifespan, displayed a similar but accelerated trend. Interestingly, the opposite trend was observed in slow-aging Snell Dwarf mice (dw/dw) and in mice fed a calorically restricted diet. We also discovered that increased expression and activity of α-1,6-fucosyltransferase (FUT8) in the liver are strongly linked to the age-related changes in glycosylation and that this increased FUT8 and fucosylation influence IGF-1 signaling. These data demonstrate that the glycosylation machinery in liver cells is significantly affected during aging and that age-related increased FUT8 activity could influence the aging process by altering the sensitivity of the IGF-1R signaling pathway.


Asunto(s)
Envejecimiento , Proteínas Sanguíneas/metabolismo , Fucosiltransferasas/sangre , Glucuronidasa/deficiencia , Glicómica/métodos , Polisacáridos/sangre , Transducción de Señal , Animales , Proteínas Sanguíneas/genética , Restricción Calórica , Fucosa/metabolismo , Fucosiltransferasas/genética , Expresión Génica , Glucuronidasa/genética , Glicoproteínas/sangre , Glicoproteínas/genética , Glicosilación , Factor I del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/metabolismo , Proteínas Klotho , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Polisacáridos/genética , Receptor IGF Tipo 1/genética , Receptor IGF Tipo 1/metabolismo
13.
Cancer Biomark ; 10(3-4): 145-54, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22674300

RESUMEN

Successful therapy of the non-small cell lung carcinoma (NSCLC) depends on its early detection, and non-invasive detection methods are preferred. As plasma proteins are modified by N-linked glycosylation, we tested the importance of the N-glycan profile in diagnosing and prognosticating NSCLC. We analysed desialylated plasma samples from 75 NSCLC patients, and 71 healthy individuals by the high-throughput DNA sequencer-based carbohydrate analytical profiling technique. We detected alterations in the levels of several N-glycans in NSCLC patients. Total α-1,6-core fucosylated biantennaries (NGA2F, NG1A2F, NA2F) and total bisecting α-1,6-core fucosylated biantennaries (NGA2FB, NA2FB) were reduced in NSCLC patients, whereas the branching α-1,3-fucosylated triantennary N-glycan (NA3FB) was increased. Best diagnostic accuracy was identified for NG1A2F. NSCLC patients with TNM stage I stage did not show further differences, but patients with higher stages did (TNM II to IV). Those patients additionally had a reduced level in the α-1,6-core fucosylated structure NA2F with parallel increase in the non-fucosylated structure NA2. In this regard, NSCLC patients with a relatively low amount of NA2 per NA2F had a better three-year survival than patients with high amount. NSCLC patients show an altered N-glycan profile of plasma proteins that may be regarded as a supportive tool for cancer diagnosis.


Asunto(s)
Biomarcadores de Tumor/sangre , Carcinoma de Pulmón de Células no Pequeñas/sangre , Neoplasias Pulmonares/sangre , Polisacáridos/sangre , Anciano , Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Femenino , Glicómica/métodos , Humanos , Neoplasias Pulmonares/diagnóstico , Masculino , Persona de Mediana Edad , Ácido N-Acetilneuramínico/química , Estadificación de Neoplasias , Polisacáridos/química , Pronóstico , Curva ROC , Análisis de Supervivencia
14.
Exp Gerontol ; 45(10): 738-43, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20801208

RESUMEN

Biomarkers indicating biological age are of significant interest for prevention, diagnosis and monitoring (and the treatment) of age-related diseases. We previously reported an alteration of serum N-glycan profile in old humans using "DNA Sequencer Adapted-Fluorophore Assisted Carbohydrate Electrophoresis" (DSA-FACE). To validate the shift in serum N-glycan profile during ageing, we studied serum N-glycan profiles in different age groups of healthy volunteers, patients with dementia, and patients with Cockayne syndrome, a genetic DNA repair disorder involving neurodegeneration and premature ageing. We found that the log of the ratio of two glycans (NGA2F and NA2F), named GlycoAgeTest, remained steady up to the age of 40years and thereafter gradually increased to reach its highest level in nonagenarians. Patients with dementia or Cockayne syndrome had a higher GlycoAgeTest level than age-matched healthy individuals. We thus demonstrate that the value of GlycoAgeTest is better than chronological age for estimating the physiological age of a human individual, and that it could be used as an ageing biomarker for healthy humans. Our data indicate that the GlycoAgeTest could be used as a non-invasive surrogate marker for general health, for forecasting disease progression during ageing, and for monitoring the efficacy of anti-ageing food compounds.


Asunto(s)
Envejecimiento/sangre , Síndrome de Cockayne/sangre , Demencia/sangre , Glicómica/métodos , Polisacáridos/sangre , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Síndrome de Cockayne/diagnóstico , Demencia/diagnóstico , Electroforesis/instrumentación , Glicómica/instrumentación , Humanos , Persona de Mediana Edad , Sensibilidad y Especificidad , Análisis de Secuencia de ADN/instrumentación , Adulto Joven
15.
Mol Cancer ; 9: 215, 2010 Aug 12.
Artículo en Inglés | MEDLINE | ID: mdl-20704698

RESUMEN

BACKGROUND: There is a demand for serum markers for the routine assessment of the progression of liver cancer. We previously found that serum N-linked sugar chains are altered in hepatocellular carcinoma (HCC). Here, we studied glycomic alterations during development of HCC in a rat model. RESULTS: Rat HCC was induced by the hepatocarcinogen, diethylnitrosamine (DENA). N-glycans were profiled using the DSA-FACE technique developed in our laboratory.In comparison with control rats, DENA rats showed a gradual but significant increase in two glycans (R5a and R5b) in serum total N-glycans during progression of liver cirrhosis and cancer, and a decrease in a biantennary glycan (P5). The log of the ratio of R5a to P1 (NGA2F) and R5b to P1 [log(R5a/P1) and log(R5b/P1)] were significantly (p < 0.0001) elevated in HCC rats, but not in rats with cirrhosis or fibrosis or in control rats. We thus propose a GlycoTest model using the above-mentioned serum glycan markers to monitor the progression of cirrhosis and HCC in the DENA-treated rat model. When DENA-treated rats were subsequently treated with farnesylthiosalicyclic acid, an anticancer drug, progression to HCC was prevented and GlycoTest markers (P5, R5a and R5b) reverted towards non-DENA levels, and the HCC-specific markers, log(R5a/P1) and log(R5b/P1), normalized completely. CONCLUSIONS: We found an increase in core-alpha-1,6-fucosylated glycoproteins in serum and liver of rats with HCC, which demonstrates that fucosylation is altered during progression of HCC. Our GlycoTest model can be used to monitor progression of HCC and to follow up treatment of liver tumors in the DENA rat. This GlycoTest model is particularly important because a rapid non-invasive diagnostic procedure for tumour progression in this rat model would greatly facilitate the search for anticancer drugs.


Asunto(s)
Biomarcadores de Tumor/sangre , Carcinógenos/toxicidad , Dietilnitrosamina/toxicidad , Neoplasias Hepáticas Experimentales/inducido químicamente , Polisacáridos/sangre , Animales , Fucosa/metabolismo , Fucosiltransferasas/genética , Hígado/enzimología , Neoplasias Hepáticas Experimentales/sangre , Ratas
16.
Liver Int ; 30(8): 1221-8, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20524982

RESUMEN

BACKGROUND AND AIMS: There is a demand for serum markers that can routinely assess the progression of liver cancer. DENA (diethylnitrosamine), a hepatocarcinogen, is commonly used in an experimental mouse model to induce liver cancer that closely mimics a subclass of human hepatocellular carcinoma (HCC). However, blood monitoring of the progression of HCC in mouse model has not yet been achieved. In this report, we studied glycomics during the development of mouse HCC induced by DENA. METHODS: Mouse HCC was induced by DENA. Serum N-glycans were profiled using the sequencer assisted-Fluorophore-assisted carbohydrate electrophoresis technique developed in our laboratory. Possible alteration in the transcription of genes relevant to the synthesis of the changed glycans was analysed by real-time polymerase chain reaction. RESULTS: In comparison with the control mice that received the same volume of saline, a tri-antennary glycan (peak 8) and a biantennary glycan (peak 4) in serum total glycans of DENA mice increased gradually but significantly during progression of liver cancer, whereas a core-fucosylated biantennary glycan (peak 6) decreased. Expression of alpha-1,6-fucosyltransferase 8 (Fut8), which is responsible for core fucosylation, decreased in the liver of DENA mice compared with that of age-matched control mice. Likewise, the expression level of Mgat4a, which is responsible for tri-antennary, significantly increased in the liver of DENA mice (P<0.001). CONCLUSIONS: The changes of N-glycan levels in the serum could be used as a biomarker to monitor the progress of HCC and to follow up the treatment of liver tumours in this DENA mouse model.


Asunto(s)
Biomarcadores de Tumor/sangre , Carcinoma Hepatocelular/diagnóstico , Neoplasias Hepáticas Experimentales/diagnóstico , Polisacáridos , Animales , Carcinoma Hepatocelular/inducido químicamente , Carcinoma Hepatocelular/metabolismo , Cartilla de ADN/genética , ADN Complementario/genética , Dietilnitrosamina/toxicidad , Electroforesis/métodos , Fucosiltransferasas/metabolismo , Hígado/patología , Neoplasias Hepáticas Experimentales/inducido químicamente , Neoplasias Hepáticas Experimentales/metabolismo , Ratones , N-Acetilglucosaminiltransferasas/metabolismo , Polisacáridos/sangre , Polisacáridos/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
17.
Rejuvenation Res ; 13(4): 439-44, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20426627

RESUMEN

We investigated whether blood N-glycan changes can be used as a diagnostic biomarker for Alzheimer disease (AD). We used DNA sequencer-assisted, fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology to assay N-glycans in sera from 79 autopsy-confirmed dementia patients and 149 healthy controls. One N-glycan (NA2F) was substantially decreased in AD patients but not in controls. Use of NA2F for discriminating AD between dementia patients and healthy controls showed a diagnostic accuracy of 85.7% +/- 2.8% with 92% specificity and 70% sensitivity. The decrease in the level of NA2F in AD patients compared to non-AD patients was more pronounced in females (p < 0.0001) than in males (p < 0.014). Use of NA2F to differentiate female AD from female non-AD patients reached a diagnostic accuracy of 90.7% +/- 4.8 %. Pearson correlation analysis showed that in female dementia patients, serum NA2F levels were significantly correlated with the cerebrospinal fluid (CSF) beta-amyloid peptide of 42 amino acids (Abeta(1-42)) and tau phosphorylated at threonine 181 (P-tau(181P)) levels, whereas in male dementia patients serum NA2F levels were significantly correlated only with CSF total tau protein (T-tau) level. Thus, we suggest that the serum N-glycan marker might be suitable for longitudinal and follow-up studies.


Asunto(s)
Enfermedad de Alzheimer/diagnóstico , Biomarcadores/análisis , Carbohidratos/análisis , Glicómica , Adulto , Enfermedad de Alzheimer/sangre , Enfermedad de Alzheimer/líquido cefalorraquídeo , Biomarcadores/sangre , Biomarcadores/líquido cefalorraquídeo , Carbohidratos/sangre , Carbohidratos/líquido cefalorraquídeo , Estudios de Casos y Controles , Electroforesis/métodos , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sensibilidad y Especificidad
18.
J Proteome Res ; 8(2): 463-70, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19140676

RESUMEN

The hepatic histology in nonalcoholic fatty liver disease can vary from isolated hepatic steatosis to steatohepatitis can progress to cirrhosis and liver-related death. The aim was to evaluate the use of blood serum N-glycan fingerprinting as a tool for differential diagnosis of nonalcoholic steatohepatitis from steatosis. A group of 47 patients with NAFLD was diagnosed by clinical laboratory analysis and ultrasonography, and was studied histologically using the Brunt's scoring system. The control group included 13 healthy individuals. N-glycan profiles of serum proteins were determined by DNA sequencer-based carbohydrate analytical profiling. We have found that the concentrations of two glycans (NGA2F and NA2) and their logarithm ratio of NGA2F versus NA2 (named GlycoNashTest) were associated with the degree of NASH-related fibrosis, but had no correlation with the grade of inflammation nor steatosis severity. When used to screen NAFLD patients, GlycoNashTest could identify advanced NASH-related fibrosis (F3-F4) with the diagnosis sensitivity of 89.5% and specificity of 71.4%. The serum N-glycan profile is a promising noninvasive method for detecting NASH or NASH-related fibrosis in NAFLD patients, which could be a valuable supplement to other markers currently used in diagnosis of NASH.


Asunto(s)
Biomarcadores , Hígado Graso/sangre , Polisacáridos/sangre , Polisacáridos/química , Biomarcadores/sangre , Biomarcadores/química , Conformación de Carbohidratos , Secuencia de Carbohidratos , Diagnóstico Diferencial , Hígado Graso/diagnóstico , Hígado Graso/patología , Humanos , Inflamación/metabolismo , Inflamación/patología , Datos de Secuencia Molecular , Curva ROC
19.
Mech Ageing Dev ; 130(1-2): 92-7, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19070631

RESUMEN

Protein glycosylation, the most common form of co-translational modification of proteins, is the enzymatic addition of sugars or oligosaccharides (glycans) to proteins. Protein glycosylation increases the diversity of the functions of proteins encoded in the genome. The result is that different glycomes of the same protein may have different functional, kinetic or physical properties. The glycosylation pathway is largely regulated by the condition of the cells, which means that the sugar chains can be altered by the physiological or pathophysiological condition of the cell. Thus, the type of glycans produced by cells, tissues, or organism could reflect their current physiological state. We determined the N-glycan profiles of serum proteins by using DNA sequencer-based carbohydrate analytical profiling technology. We show that two N-glycan structures (NGA2F and NA2F) present in human blood glycoproteins change with ageing, and that one triantennary glycan (NA3Fb) is correlated with tumor stage in HCC patients. Therefore, examining alterations in serum glycan fingerprint by using our platform could be a suitable tool for monitoring the healthiness of ageing and for the follow-up of pathophysiological conditions such as liver cancer.


Asunto(s)
Envejecimiento/metabolismo , Carcinoma Hepatocelular/diagnóstico , Carcinoma Hepatocelular/metabolismo , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/metabolismo , Polisacáridos/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/metabolismo , Proteínas Sanguíneas/metabolismo , Glicómica , Glicosilación , Humanos , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Curva ROC , Sensibilidad y Especificidad
20.
Rejuvenation Res ; 11(6): 1013-20, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19072255

RESUMEN

Experiments in lower organisms, such as worms and flies, indicate that the molecular chaperone protein heat shock protein 70 (HSP70) is a longevity factor. In contrast, we demonstrate here that mice overexpressing HSP70 display growth retardation and early death. HSP70 transgenic mice displayed increased levels of serum corticosterone and weaker expression and activity of the glucocorticoid receptor in the liver. Serum insulin-like growth factor-1 (IGF-1) concentrations in the transgenic mice were 50% lower than in the control mice, leading to growth retardation. HSP70 transgenic mice showed decreased expression of Casp9, which encodes caspase-9, and increased expression of the anti-apoptotic Bcl-2 gene, indicating that apoptosis is suppressed. Consequently, most of the transgenic animals died before the age of 18 months from tumors in their lungs and lymph nodes. We suggest that the proinflammatory and antiapoptotic effects of HSP70 might be responsible for the growth retardation, tumor formation, and early death observed in the HSP70 transgenic mice.


Asunto(s)
Trastornos del Crecimiento/etiología , Proteínas HSP70 de Choque Térmico/genética , Neoplasias Experimentales/etiología , Animales , Caspasa 9/genética , Caspasa 9/metabolismo , Muerte Celular , Corticosterona/sangre , Femenino , Expresión Génica , Proteínas HSP70 de Choque Térmico/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Masculino , Ratones , Ratones Transgénicos , Neoplasias Experimentales/genética , Neoplasias Experimentales/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA